Hasnain Faheem 4
4 · Kura Oncology, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Hasnain Faheem
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$3.12/sh+10,000$31,200→ 33,983 total - Sale
Common Stock
2025-12-09$10.98/sh−10,000$109,764→ 23,983 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $10.60 to $11.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.